×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
上海中医药大学 [8]
合肥物质科学研究院 [8]
山东大学 [4]
复旦大学上海医学院 [4]
暨南大学 [3]
中国医学科学院 北京... [3]
更多...
内容类型
期刊论文 [29]
学位论文 [14]
会议论文 [1]
发表日期
2021 [1]
2019 [4]
2018 [2]
2017 [9]
2016 [4]
2015 [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共44条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Chronic exposure to PPCPs mixture at environmentally relevant concentrations (ERCs) altered carbohydrate and lipid metabolism through gut and liver toxicity in zebrafish
期刊论文
ENVIRONMENTAL POLLUTION, 2021, 卷号: 273, 页码: 10
作者:
Hamid, Naima
;
Junaid, Muhammad
;
Wang, Yan
;
Pu, Shi-Ya
;
Jia, Pan-Pan
收藏
  |  
浏览/下载:93/0
  |  
提交时间:2021/05/17
Hepatotoxicity
Gut homeostasis
Chronic exposure
Lipid metabolism
Zebrafish
Variants of INSR rs2963 is Associated With Gestational Diabetes Mellitus and Iron Storage
会议论文
作者:
Liu, Junxiu
;
Cheng, Yan
;
Zhang, Qingying
;
He, Mulan
;
Li, Tingting
收藏
  |  
浏览/下载:0/0
  |  
提交时间:2019/12/05
A novel recombinant peptide INSR-IgG4Fc restores insulin sensitivity in experimental insulin resistance models.
期刊论文
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, 卷号: Vol.109, 页码: 1276-1286
作者:
Wang Jing
;
Shi Zhe
;
Zou Tao
;
Zou Min-Xu
;
Yang Hui-Xian
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2019/12/13
Insulin
resistance
PI3K-Akt
pathway
Recombinant
peptide
Type
2
diabetes
mellitus
Yiminsu
A novel recombinant peptide INSR-IgG4Fc (Yiminsu) restores insulin sensitivity in experimental insulin resistance models
期刊论文
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, 卷号: 109, 页码: 1276-1286
作者:
Wang, Jing
;
Shi, Zhe
;
Zou, Tao
;
Zou, Min-Xu
;
Yang, Hui-Xian
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/27
Insulin resistance
PI3K-Akt pathway
Recombinant peptide
Type 2 diabetes mellitus
Yiminsu
A novel recombinant peptide INSR-IgG4Fc (Yiminsu) restores insulin sensitivity in experimental insulin resistance models
期刊论文
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, 卷号: 109, 页码: 1276-1286
作者:
Wang, Jing
;
Shi, Zhe
;
Zou, Tao
;
Zou, Min-Xu
;
Yang, Hui-Xian
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/27
Insulin resistance
PI3K-Akt pathway
Recombinant peptide
Type 2 diabetes mellitus
Yiminsu
Sterol O-acyltransferase 1 deficiency improves defective insulin signaling in the brains of mice fed a high-fat diet
期刊论文
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 卷号: 499, 期号: 2
作者:
Xu, Ning
;
Meng, Hao
;
Liu, Tian-Yi
;
Feng, Ying-Li
;
Qi, Yuan
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/05
High-fat diet
Hypothalamic insulin resistance
SOAT1
Metabolic syndrome
p-INSR
p-AMPK alpha
One Novel 2.43Kb Deletion and One Single Nucleotide Mutation of the INSR Gene in a Chinese Neonate with Rabson-Mendenhall Syndrome
期刊论文
JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2018, 卷号: 10, 期号: 2
作者:
Chen, Xiang
;
Wang, Huijun
;
Wu, Bingbing
;
Dong, Xinran
;
Liu, Bo
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/05
Insulin receptor gene
Rabson-Mendenhall syndrome
neonate
mutation
next generation sequencing
Discovery of (R)-1-(3-(4-Amino-3-(3-chloro-4-(pyridin-2-ylmethoxy)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one (CHMFL-EGFR-202) as a Novel Irreversible EGFR Mutant Kinase Inhibitor with a Distinct Binding Mode
期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 60, 期号: 7, 页码: 2944-2962
作者:
Wang, Aoli
;
Li, Xixiang
;
Wu, Hong
;
Zou, Fengming
;
Yan, Xiao-E
收藏
  |  
浏览/下载:35/0
  |  
提交时间:2018/07/26
Discovery of (R)-1-(3-(4-Amino-3-(3-chloro-4-(pyridin-2-ylmethoxy)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one (CHMFL-EGFR-202) as a Novel Irreversible EGFR Mutant Kinase Inhibitor with a Distinct Binding Mode
期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 60, 期号: 7, 页码: 2944-2962
作者:
Wang, Aoli
;
Li, Xixiang
;
Wu, Hong
;
Zou, Fengming
;
Yan, Xiao-E
收藏
  |  
浏览/下载:44/0
  |  
提交时间:2018/07/26
Discovery of (R)-1-(3-(4-Amino-3-(3-chloro-4-(pyridin-2-ylmethoxy)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one (CHMFL-EGFR-202) as a Novel Irreversible EGFR Mutant Kinase Inhibitor with a Distinct Binding Mode
期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 60, 期号: 7, 页码: 2944-2962
作者:
Wang, Aoli
;
Li, Xixiang
;
Wu, Hong
;
Zou, Fengming
;
Yan, Xiao-E
收藏
  |  
浏览/下载:35/0
  |  
提交时间:2018/07/26
©版权所有 ©2017 CSpace - Powered by
CSpace